The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
In most emergency departments, beds are a hot commodity. But some patients don’t actually need a bed for their treatment – and accurately identifying those people is a low-lift but effective way to increase efficiency without sacrificing care quality, finds a study recently published in the journal Management Science.
The researchers developed a simple decision tree, informed by mathematical and machine learning models, to help staff decide whether a patient truly needs a bed or can be routed to a “vertical processing pathway” – that is, an area where they can be treated sitting up. Many hospitals already have such an area but don’t necessarily have a systematic way to decide which patients are treated there.
Diversity alone won’t get the votes for funding public education. It takes communities that are more integrated and connected, where residents have a sense of shared stake.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
The world has marveled at the speed with which science took on and solved the task of creating effective vaccines for Covid-19. But another often-overlooked science — the engineering and management science of operations research — is now equally important for getting vaccines into the arms of Americans.
CATONSVILLE, MD, March 24, 2021 – COVID-19 has been shown to spread on airplanes by infected passengers, so minimizing the risk of secondary infections aboard aircraft may save lives. New research in the INFORMS journal Service Science uses two models to help solve the airplane seating assignment problem (ASAP). The models can lower the transmission risk of COVID-19 more so than the strategy of blocking the middle seats, given the same number of passengers.
The first Covid-19 vaccine candidate went into the arms of volunteers in Seattle in March 2020. It was an mRNA vaccine from Moderna. The mRNA candidate from BioNTech and Pfizer followed in April. By December 2020, these two had become the first vaccines to be approved by the US Food and Drug Administration (FDA). Hot on their heels are rivals based on adenovirus vectors from AstraZeneca and Johnson & Johnson, as well as Sputnik V from Russia.
As more people get vaccinated, doctors say we need to start thinking about moving vaccines from mass vaccination sites to health care facilities, such as doctors' offices.
Disruptions in the global high-tech supply chain spell bad news for Chevy Silverados and Samsung phones alike.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine